NCT00072072View on ClinicalTrials.gov

Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2003

Study Completion Date

January 31, 2006

Conditions
Lung Cancer
Interventions
DRUG

celecoxib

DRUG

erlotinib hydrochloride

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00072072 - Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter